Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2025-12-19

Clinical Trial Update: A Study to Investigate the Course of Synovial Hypertrophy in Patients With Haemophilia A on Efanesoctocog Alfa Prophylaxis [Phase 4]

View source ↗

Summary

ClinicalTrials.gov study evaluating the progression of synovial hypertrophy in Haemophilia A patients on efanesoctocog alfa prophylaxis (Phase 4); the study is …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Efanesoctocog alfa (efanesoctocog alfa)

Snippet

Sponsor: Swedish Orphan Biovitrum | Conditions: Haemophilia A (Moderate or Severe), Hemophilia, Classic | Phase 4 | Status: ACTIVE_NOT_RECRUITING